CB2 receptor may exert an important inhibitory effect in stress-induced colonic hypermotility by modulating NO synthesis through p38 mitogen-activated protein kinase signaling. AM1241 could be used as a potential drug to treat disorders with colonic hypermotility.
Activation of cannabinoid 2 receptor relieves colonic hypermotility in a rat model of irritable bowel syndrome
© 2024 · Veterinary Cannabis Society